The US biotech’s neurological drug candidate showed a reduction in disease progression of at least 50% and the company will ...

The small molecule drug arimoclomol (Miplyffa) has got the green light from the U.S. Food and Drug Administration (FDA) for ...

The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...

The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

The series A financing will enable Nura Bio to advance its lead drug candidate into the next stage of clinical trials, ...

Applying AI-enabled route scouting services allows drug developers to avoid pitfalls that can typically occur in drug ...

Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.

Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have ...

Motif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its ...

The European Organisation for Research and Treatment of Cancer (EORTC) has renewed and extended its partnership with Medidata ...

Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligence’s (AI's) ...

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal ...